{
    "root": "31571b36-5ea5-8448-e063-6294a90a8622",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": {
        "text": "Diclofenac Sodium",
        "suffix": {
            "text": "Delayed Release"
        }
    },
    "value": "20250327",
    "ingredients": [
        {
            "name": "FERROSOFERRIC OXIDE",
            "code": "XM0M87F357"
        },
        {
            "name": "HYPROMELLOSES",
            "code": "3NXW29V3WO"
        },
        {
            "name": "LACTOSE MONOHYDRATE",
            "code": "EWQ57Q8I5X"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30"
        },
        {
            "name": "METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:1)",
            "code": "74G4R6TH13"
        },
        {
            "name": "CELLULOSE, MICROCRYSTALLINE",
            "code": "OP1R32D61U"
        },
        {
            "name": "SHELLAC",
            "code": "46N107B71O"
        },
        {
            "name": "POLYETHYLENE GLYCOL 2000",
            "code": "HAF0412YIT"
        },
        {
            "name": "POVIDONE",
            "code": "FZ989GH94E"
        },
        {
            "name": "SODIUM STARCH GLYCOLATE TYPE A POTATO",
            "code": "5856J3G2A2"
        },
        {
            "name": "TALC",
            "code": "7SEV7J4R1U"
        },
        {
            "name": "TITANIUM DIOXIDE",
            "code": "15FIX9V2JP"
        },
        {
            "name": "DICLOFENAC SODIUM",
            "code": "QTG126297Q"
        }
    ],
    "indications": "Carefully consider the potential benefits and risks of diclofenac sodium delayed-release tablets and other treatment options before deciding to use diclofenac. Use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (\n \n  see\n  \n   WARNINGS; Gastrointestinal Bleeding, Ulceration, and Perforation\n                     ).\n\n \n                  Diclofenac is indicated:\n                  \n                     For relief of the signs and symptoms of osteoarthritis\n                     For relief of the signs and symptoms of rheumatoid arthritis\n                     For acute or long-term use in the relief of signs and symptoms of ankylosing spondylitis",
    "contraindications": "Carefully consider the potential benefits and risks of diclofenac sodium delayed-release tablets and other treatment options before deciding to use diclofenac. Use the lowest effective dose for the shortest duration consistent with individual patient treatment goals\n \n  (see\n  \n   WARNINGS; Gastrointestinal Bleeding, Ulceration, and Perforation)\n \n  .\n\n \n                  After observing the response to initial therapy with diclofenac, the dose and frequency should be adjusted to suit an individual patient's needs.\n                  For the relief of osteoarthritis, the recommended dosage is 100-150 mg/day in divided doses (50 mg twice a day or three times a day, or 75 mg twice a day).\n                  For the relief of rheumatoid arthritis, the recommended dosage is 150-200 mg/day in divided doses (50 mg three times a day. or four times a day, or 75 mg twice a day.).\n                  For the relief of ankylosing spondylitis, the recommended dosage is 100-125 mg/day, administered as 25 mg four times a day, with an extra 25-mg dose at bedtime if necessary.",
    "warningsAndPrecautions": "Diclofenac sodium delayed-release tablets\n                  50 mg – white to off-white, biconvex, round-shaped, unscored (imprinted   on one side), supplied in\n                  NDC: 70518-2707-00\n                  NDC: 70518-2707-01\n                  NDC: 70518-2707-02\n                  PACKAGING: 90 in 1 BOTTLE PLASTIC\n                  PACKAGING: 60 in 1 BOTTLE PLASTIC\n                  PACKAGING: 60 in 1 BOTTLE PLASTIC\n                  \n                  Store at room temperature 20°C to 25°C (68°F to 77°F); excursions permitted between 15°C to 30°C (59°F to 86°F) [see USP Controlled Room Temperature].\n                  Protect from moisture.\n                  Dispense in tight container (USP).\n                  \n                  Repackaged and Distributed By:\n                  Remedy Repack, Inc.\n                  625 Kolter Dr. Suite #4 Indiana, PA 1-724-465-8762",
    "adverseReactions": "Diclofenac sodium delayed-release tablets are contraindicated in the following patients:\n                  \n                     Known hypersensitivity (e.g., anaphylactic reactions and serious skin reactions) to diclofenac or any components of the drug product (\n  \n   see\n   \n    WARNINGS; Anaphylactic Reactions,\n   \n    Serious Skin Reactions\n                        ).\n \n  \n                     History of asthma, urticaria, or other allergic-type reactions after taking aspirin or other NSAIDs. Severe, sometimes fatal, anaphylactic reactions to NSAIDs have been reported in such patients (\n  \n   see\n   \n    WARNINGS; Anaphylactic Reaction,\n   \n    Exacerbation of Asthma Related to Aspirin Sensitivity\n                        ).\n \n  \n                     In the setting of coronary artery bypass graft (CABG) surgery (\n  \n   see\n   \n    Warnings; Cardiovascular Thrombotic Events\n                        )."
}